Page last updated: 2024-08-25

doripenem and Cross Infection

doripenem has been researched along with Cross Infection in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	17 (40.48)	29.6817
2010's	22 (52.38)	24.3611
2020's	3 (7.14)	2.80

Authors

Authors	Studies
Bonomo, RA; Decker, BK; Hujer, AM; Hujer, KM; Perez, F; Rather, PN	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Abdelraouf, K; Ameka, M; Brioso, CG; Caeiro, JP; Chang, KT; Garey, KW; McCaskey, LA; Tam, VH; Weston, JS	1
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G	1
Chang, H; Lee, CM; Lee, MC; Lu, CH; Sun, FJ; Wu, AY	1
Bruno, CJ; Kollef, MH; Réa-Neto, Á; Rhee, EG; Wunderink, RG	1
Lai, CC; Tang, HJ	1
Chuang, YC; Liu, WD; Sheng, WH; Shih, MC; Wang, JT	1
Kaniga, K; Lee, M; Redman, R; Rice, DA	1
Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S	1
Chida, K; Harada, M; Inui, N; Matsuo, Y; Nakamura, Y; Suda, T; Wajima, T	1
Taylor, B; Taylor, SP	1
Abbasi, SA; Day, KM; Paterson, DL; Perry, JD; Raza, MW; Sartor, AL; Sidjabat, HE	1
Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H	1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N	1
Chao, CM; Chen, CC; Chuang, YC; Huang, HL; Lai, CC; Tang, HJ	1
Friedland, I; Kaniga, K; Ketter, N; Lee, M; Lobo, SM; Niederman, M; Prokocimer, P; Réa-Neto, A; Schroeder, E	1
Goff, DA; Mangino, JE; Schafer, JJ	1
Micek, ST; Neuner, EA; Ritchie, DJ	1
Dedhia, HV; McKnight, R	1
Mandell, L	1
Restrepo, MI	1
File, TM; Redman, R	1
Amin, A	1
Fisher, AC; Jenkins, SG; Kaniga, K; Nicholson, SC; Peterson, JA	1
Guery, BP	1
Akhras, K; Caro, JJ; Kongnakorn, T; Merchant, S; Mwamburi, M; Nathwani, D	1
Lin, R; Nandy, P; Samtani, MN	1
Buron, JA; Cerrato, SG; Garau, J; Rello, J; Rodriguez, JA; Rossolini, GM; Zaragoza, R	1
Aguado, JM	1
Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC	1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN	1
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G	1
Apisarnthanarak, A; Mundy, LM	1
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA	1
Chang, SC; Dong, SX; Wang, JT	1
Lipman, J; Roberts, JA	1
Weigelt, JA	1
Joseph, J; Rodvold, KA	1
Giamarellou, H; Kanellakopoulou, K	1

Reviews

11 review(s) available for doripenem and Cross Infection

Article	Year
Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans	2007
Doripenem: a new addition to the carbapenem class of antimicrobials. Recent patents on anti-infective drug discovery, 2009, Volume: 4, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2009
New antibiotics for healthcare-associated pneumonia. Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin	2009
Doripenem: position in clinical practice. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections	2009
Doripenem: a new carbapenem in the treatment of nosocomial infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials. Current medical research and opinion, 2009, Volume: 25, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2009
[Doripenem: need for a new carbapenem]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections	2009
[Role of new carbapenems in nosocomial intraabdominal infection]. Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28 Suppl 2 Topics: Abdomen; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Humans; Multicenter Studies as Topic; Postoperative Complications; Pseudomonas Infections; Randomized Controlled Trials as Topic; Soft Tissue Infections	2010
Empiric treatment options in the management of complicated intra-abdominal infections. Cleveland Clinic journal of medicine, 2007, Volume: 74 Suppl 4 Topics: Anti-Bacterial Agents; Carbapenems; Community-Acquired Infections; Cross Infection; Doripenem; Drug Resistance, Bacterial; General Surgery; Humans; Internal Medicine; Minocycline; Peritoneal Cavity; Peritonitis; Risk Factors; Severity of Illness Index; Surgical Wound Infection; Tigecycline	2007
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome	2008
Current therapies for pseudomonas aeruginosa. Critical care clinics, 2008, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic	2008

Trials

4 trial(s) available for doripenem and Cross Infection

Article	Year
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials. International journal of antimicrobial agents, 2013, Volume: 41, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections	2013
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Current medical research and opinion, 2008, Volume: 24, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Tazobactam; Treatment Outcome	2008
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult	2010
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility. Critical care medicine, 2013, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Monte Carlo Method; Obesity; Pneumonia, Bacterial	2013

Other Studies

27 other study(ies) available for doripenem and Cross Infection

Article	Year
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Texas	2010
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction	2011
Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan. The American journal of tropical medicine and hygiene, 2022, 08-17, Volume: 107, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Doripenem; Escherichia coli; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Taiwan; Tertiary Care Centers	2022
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply. The Lancet. Infectious diseases, 2020, Volume: 20, Issue:1 Topics: Cephalosporins; Cross Infection; Doripenem; Double-Blind Method; Humans; Meropenem; Pneumonia, Ventilator-Associated; Tazobactam	2020
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia. The Lancet. Infectious diseases, 2020, Volume: 20, Issue:1 Topics: Cephalosporins; Cross Infection; Doripenem; Double-Blind Method; Humans; Meropenem; Pneumonia, Ventilator-Associated; Tazobactam	2020
Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:5 Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Regression Analysis; Retrospective Studies; Taiwan	2019
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin	2013
Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia. International journal of antimicrobial agents, 2013, Volume: 42, Issue:2 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chromatography, Liquid; Cross Infection; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Plasma; Pneumonia, Bacterial; Tandem Mass Spectrometry; Time Factors	2013
Pseudohemoptysis due to Serratia marcescens. Journal of general internal medicine, 2014, Volume: 29, Issue:6 Topics: Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Diagnosis, Differential; Doripenem; Hemoptysis; Humans; Male; Serratia Infections; Serratia marcescens; Sputum; Treatment Outcome	2014
Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Acinetobacter baumannii; Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Doripenem; Enterobacteriaceae; Fosfomycin; Humans; Meropenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pakistan; Thienamycins	2014
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii. Journal of applied microbiology, 2016, Volume: 121, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins	2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical therapeutics, 2016, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam	2016
Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections. PloS one, 2016, Volume: 11, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cross Infection; Doripenem; Female; Hospital Mortality; Humans; Intraabdominal Infections; Male; Middle Aged; Respiratory Tract Infections; Retrospective Studies; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Urinary Tract Infections	2016
Efficacy of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated	2009
Safety of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control	2009
Clinical and economic consequences of ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index	2009
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation. Current medical research and opinion, 2010, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Humans; Pneumonia; United States	2010
The changing face of antibiotic therapy. British journal of hospital medicine (London, England : 2005), 2009, Volume: 70, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Delayed-Action Preparations; Doripenem; Drug Resistance, Bacterial; Humans; Infection Control; Treatment Outcome	2009
Nosocomial infections: new therapeutic alternatives. Expert review of anti-infective therapy, 2010, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic	2010
Comparative activity of carbapenem testing: the COMPACT study. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5 Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins	2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey	2011
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins	2012
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors	2012
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic	2012
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins	2012
Doripenem (doribax)--a new parenteral carbapenem. Obstetrics and gynecology, 2008, Volume: 111, Issue:5 Topics: Carbapenems; Cross Infection; Doripenem; Female; Humans; Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2008